At that time, GLP-1 receptor agonists were approved and widely used for the treatment of type 2 diabetes.
The safety and efficacy of medications, including GLP-1 receptor agonists, are continuously monitored by regulatory agencies and healthcare authorities. Any concerns related to safety or adverse effects are taken seriously, and appropriate actions may be taken if necessary. However, it is challenging to determine with certainty whether a specific medication will be banned or restricted due to safety concerns in the future.
GLP-1 receptor agonists have generally shown to be effective and well-tolerated in treating type 2 diabetes, with some common side effects such as nausea and vomiting, though serious adverse events are rare.
It is essential for patients and healthcare professionals to stay informed about the latest updates and recommendations from health authorities to ensure the safe and effective use of medications. If you have concerns about the safety of any medication, it's best to consult with a healthcare provider who can provide you with the most current information and guidance.